Funding for this research was provided by:
National Academy of Sciences (1)
Received: 3 July 2019
Accepted: 1 October 2019
First Online: 29 October 2019
Ethics approval and consent to participate
: This research was approved by the Brown University IRB.
: All of the authors have reviewed and approved the manuscript for publication.
: Dr. Karl Kelsey is a founder and advisor for Cellintec. The other authors declare they have no actual or potential competing financial interests.